STAT3 is constitutively activated in ~70% of human cancers, and is downstream of many oncogenic signals and mutations, such as a series of growth factors (e.g., EGF) and cytokines (e.g., IL-6) as well as JAK1 mutants (e.g., G1097D)6,26. The gene discussed is EGF; the disease is cancer.